The Company

Sunshine Biopharma Inc. is a Colorado corporation headquartered in the greater Montreal area (Canada). The Company is fully reporting in the U.S. (www.SEC.gov) and Canada (www.SEDAR.com). Sunshine Biopharma’s shares of Common Stock are traded on the OTC market (otcmarkets.com) under the ticker symbol SBFM. Sunshine Biopharma is engaged in the following business operations:

Proprietary Anticancer Drug Development
Since inception, Sunshine Biopharma has been involved in the development Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). These and other preclinical results have been published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012. Adva-27a is the only compound known that is capable of destroying Multidrug Resistant Cancer cells. The Company is planning to conduct Adva-27a Phase I Clinical Trials for Pancreatic Cancer indication at McGill University's Jewish General Hospital in Montreal (Canada). Sunshine Biopharma is direct owner of all worldwide patents covering Adva-27a, including all issued and pending patents under PCT/FR2007/000697 and PCT/CA2014/000029. Learn more…

Essential Brand Dietary Supplements
In December 2018, Sunshine Biopharma completed the development of Essential 9™, the first in a line of essential micronutrients products that the Company is planning to launch. On December 14, 2018, Health Canada issued NPN 80089663 through which it authorized Sunshine Biopharma to manufacture and sell the Essential 9™ product. Essential 9™ dietary supplement tablets contain a balanced formula of the 9 essential amino acids that the human body cannot make. Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes. Sunshine Biopharma’s Essential 9™ provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9™ is available here, on Amazon and soon in stores.

Certified Analytical Chemistry Testing Services
Sunshine Biopharma offers certified testing services of pharmaceutical and other industrial samples through its wholly owned subsidiary, Atlas Pharma Inc. Atlas’ operations are authorized by a Drug Establishment License issued by Health Canada. Atlas is also registered with the FDA. To learn more, please visit Atlas Pharma's website (www.atlaspharmainc.ca) or call 450-682-8000.

Generic Pharmaceuticals
Sunshine Canada has licensing agreements for four (4) generic prescription drugs:

  • Anastrozole for treatment of Breast Cancer
  • Letrozole for treatment of Breast Cancer
  • Bicalutamide for treatment of Prostate Cancer
  • Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)
Please call or email us to learn more.